JP2006515013A - グリコーゲン合成酵素キナーゼ3β活性抑制剤、組成物及びその製造方法 - Google Patents
グリコーゲン合成酵素キナーゼ3β活性抑制剤、組成物及びその製造方法 Download PDFInfo
- Publication number
- JP2006515013A JP2006515013A JP2005518551A JP2005518551A JP2006515013A JP 2006515013 A JP2006515013 A JP 2006515013A JP 2005518551 A JP2005518551 A JP 2005518551A JP 2005518551 A JP2005518551 A JP 2005518551A JP 2006515013 A JP2006515013 A JP 2006515013A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- optionally substituted
- mmol
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 C*(C)(C1C(OC)=C=C2)C(C3(C)C=CC(*)=C(*)[C@]3*)=*C1=C2C(*(*)*N(C)C=CC)=O Chemical compound C*(C)(C1C(OC)=C=C2)C(C3(C)C=CC(*)=C(*)[C@]3*)=*C1=C2C(*(*)*N(C)C=CC)=O 0.000 description 13
- QVDWKLDUBSJEOG-UHFFFAOYSA-N COC(c(cc1N)ccc1OC)=O Chemical compound COC(c(cc1N)ccc1OC)=O QVDWKLDUBSJEOG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030004607 | 2003-01-23 | ||
KR20030004608 | 2003-01-23 | ||
KR20030042442 | 2003-06-27 | ||
PCT/KR2004/000097 WO2004065370A1 (en) | 2003-01-23 | 2004-01-20 | Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006515013A true JP2006515013A (ja) | 2006-05-18 |
Family
ID=36146164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005518551A Ceased JP2006515013A (ja) | 2003-01-23 | 2004-01-20 | グリコーゲン合成酵素キナーゼ3β活性抑制剤、組成物及びその製造方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7179832B2 (de) |
EP (1) | EP1590333A4 (de) |
JP (1) | JP2006515013A (de) |
KR (1) | KR100791252B1 (de) |
WO (1) | WO2004065370A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010058512A1 (en) * | 2008-11-20 | 2010-05-27 | Oncotherapy Science, Inc. | Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005118543A1 (ja) * | 2004-06-03 | 2005-12-15 | Ono Pharmaceutical Co., Ltd. | キナーゼ阻害薬およびその用途 |
TWI375673B (en) | 2005-04-11 | 2012-11-01 | Abbott Lab | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
US7728026B2 (en) | 2005-04-11 | 2010-06-01 | Abbott Laboratories, Inc. | 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors |
EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
UY29823A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones |
UY29825A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones |
EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
CN101309908A (zh) | 2005-11-15 | 2008-11-19 | 艾博特公司 | 作为有效parp抑制剂的取代的1h-苯并咪唑-4-甲酰胺化合物 |
AU2006327243A1 (en) | 2005-12-21 | 2007-06-28 | Decode Genetics Ehf | N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation |
KR20070077468A (ko) * | 2006-01-23 | 2007-07-26 | 크리스탈지노믹스(주) | 단백질 키나아제 활성을 저해하는 이미다조피리딘 유도체,이의 제조방법 및 이를 함유하는 약학 조성물 |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
MX2008014004A (es) | 2006-05-02 | 2008-11-12 | Abbott Lab | 1h-benzimidazol-4-carboxamidas sustituidas son inhibidores de parp potentes. |
EP2021000A2 (de) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenese mittels angiotensin-modulation |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
ATE523497T1 (de) | 2006-11-15 | 2011-09-15 | High Point Pharmaceuticals Llc | Neue 2-(2-hydroxyphenyl)benzimidazole, die sich für die behandlung von obesitas und diabetes eignen |
CA2669874A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
WO2008059023A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
MX2009010165A (es) * | 2007-03-30 | 2009-10-12 | Astrazeneca Ab | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. |
US8067613B2 (en) | 2007-07-16 | 2011-11-29 | Abbott Laboratories | Benzimidazole poly(ADP ribose)polymerase inhibitors |
BRPI0916726A2 (pt) * | 2008-07-30 | 2017-07-04 | Oncotherapy Science Inc | derivados de benzoimidazol e inibidores de glicogêncio sintase quinase-3 beta contendo os mesmos |
CN102271514A (zh) * | 2008-10-30 | 2011-12-07 | 肿瘤疗法科学股份有限公司 | 7-羟基-苯并咪唑-4-基-甲酮衍生物以及包含其的pbk抑制剂 |
WO2010083199A1 (en) | 2009-01-19 | 2010-07-22 | Abbott Laboratories | Benzthiazole inhibitors of poly(adp-ribose)polymerase |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
NZ598009A (en) | 2009-07-10 | 2013-11-29 | Decode Genetics Ehf | Genetic markers associated with risk of diabetes mellitus |
US9452980B2 (en) * | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
DE102011106990B3 (de) * | 2011-07-08 | 2013-01-03 | Technische Universität Darmstadt | Verbindungen als Glykogen Synthase Kinase 3 (GSK-3) Inhibitoren für die Behandlung von GSK-3-vermittelten Erkrankungen |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529773A (en) * | 1982-03-17 | 1985-07-16 | David Witiak | Alkali-soluble emulsion polymers in acidic surfactant compositions |
GB2245279B (en) * | 1990-06-20 | 1993-04-07 | Unilever Plc | Shampoo composition |
FR2676923B1 (fr) * | 1991-06-03 | 1995-04-21 | Oreal | Composition de traitement des matieres keratiniques a base de silicone et de latex. |
DE4330959A1 (de) * | 1993-09-09 | 1995-03-16 | Schering Ag | Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
US5534265A (en) * | 1994-08-26 | 1996-07-09 | The Procter & Gamble Company | Thickened nonabrasive personal cleansing compositions |
US5821258A (en) * | 1994-12-27 | 1998-10-13 | Mitsui Chemicals, Inc. | Phenylbenzimidazole derivatives |
HUP9901092A3 (en) * | 1995-08-02 | 2001-11-28 | Univ Newcastle Ventures Ltd | Benzimidazole compounds and their pharmaceutical use |
ID28846A (id) * | 1998-11-17 | 2001-07-05 | Basf Ag | 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya |
WO2002102978A2 (en) * | 2001-06-15 | 2002-12-27 | Genentech, Inc. | Human growth hormone antagonists |
-
2004
- 2004-01-20 WO PCT/KR2004/000097 patent/WO2004065370A1/en active Application Filing
- 2004-01-20 US US10/543,177 patent/US7179832B2/en not_active Expired - Fee Related
- 2004-01-20 JP JP2005518551A patent/JP2006515013A/ja not_active Ceased
- 2004-01-20 EP EP04703520A patent/EP1590333A4/de not_active Withdrawn
- 2004-01-20 KR KR1020057013355A patent/KR100791252B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010058512A1 (en) * | 2008-11-20 | 2010-05-27 | Oncotherapy Science, Inc. | Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives |
Also Published As
Publication number | Publication date |
---|---|
KR100791252B1 (ko) | 2008-01-03 |
US20060079521A1 (en) | 2006-04-13 |
KR20050109930A (ko) | 2005-11-22 |
EP1590333A4 (de) | 2008-04-30 |
US7179832B2 (en) | 2007-02-20 |
WO2004065370A1 (en) | 2004-08-05 |
EP1590333A1 (de) | 2005-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006515013A (ja) | グリコーゲン合成酵素キナーゼ3β活性抑制剤、組成物及びその製造方法 | |
JP7352662B2 (ja) | ベンゾイソオキサゾールスルホンアミド誘導体 | |
KR100815772B1 (ko) | 신규 고리상 아미드 유도체 | |
CA2816753A1 (en) | N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases | |
WO2000064894A1 (fr) | Composes 5-pyridyle-1,3-azole, leur procede de fabrication et leur utilisation | |
WO2013019653A1 (en) | Compounds and methods | |
WO2001081345A1 (fr) | Composes d'amides aromatiques | |
JP2003532730A (ja) | 細胞増殖抑制剤として有用な1,1−ジオキソイソチアゾリジンを持つインダゾール | |
WO2007063925A1 (ja) | 2-アミノベンズアミド誘導体 | |
JP5734532B2 (ja) | アゾールベンゼン誘導体 | |
JP2009542752A (ja) | 置換イソオキサゾリン、それを含有する医薬組成物、それを調製する方法、及びその使用 | |
EP2736330A1 (de) | Verbindungen und verfahren | |
KR20080072688A (ko) | 옥사디아졸 유도체 | |
KR101386679B1 (ko) | 신규한 아릴피페라진-함유 이미다졸 4-카복사마이드 유도체 및 이를 포함하는 약학 조성물 | |
EP1828177A2 (de) | Neue mch-rezeptorantagonisten | |
JP6134072B2 (ja) | キサンチンオキシダーゼ阻害薬 | |
WO2012028629A1 (en) | 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors | |
WO2014070978A1 (en) | Inhibitors of cytomegalovirus | |
IL269119B2 (en) | Dual inhibitors of magl and faah | |
WO2017073743A1 (ja) | 三環性化合物 | |
US7166624B2 (en) | Peptide deformylase inhibitors | |
WO1999061412A1 (fr) | Derives d'acide hydroxamique et utilisation medicinale de ces derives | |
JPH05239065A (ja) | 三環性複素環類、その製造法及び剤 | |
CA3215443A1 (en) | Substituted pyrrole carboxamides, process for their preparation and their use as kinase inhibitors | |
KR20240046553A (ko) | Sting 길항제로서의 소분자 우레아 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090407 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090707 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090825 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091125 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091202 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091225 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100202 |
|
A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20100622 |